Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | activated by phosphorylation | Rattus norvegicus |
Application | Comment | Organism |
---|---|---|
medicine | MG132 may be used as a pharmacological inhibitor of cardiac hypertrophy | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
MG132 | - |
Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + a protein | Rattus norvegicus | - |
ADP + a phosphoprotein | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
male Sprague-Dawley rat | - |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | - |
Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
heart | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + a protein | - |
Rattus norvegicus | ADP + a phosphoprotein | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ERK1/2 | - |
Rattus norvegicus |
JNK1 | - |
Rattus norvegicus |
MAP kinase | - |
Rattus norvegicus |
mitogen-activated kinase | - |
Rattus norvegicus |
p38 | - |
Rattus norvegicus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Rattus norvegicus |